211314-90-8

Usage

Uses

Used in Pharmaceutical Synthesis:
2-(4-bromophenyl)propan-1-amine hydrochloride is used as a key intermediate for the synthesis of various pharmaceuticals. Its unique structure allows for the creation of a wide range of medicinal compounds, contributing to the development of new treatments and therapies.
Used in Research Chemicals:
In the field of research, 2-(4-bromophenyl)propan-1-amine hydrochloride is utilized as a reagent for studying the properties and reactions of phenethylamine derivatives. Its versatility in organic chemistry makes it a valuable tool for scientific exploration and the advancement of chemical knowledge.
Used in Organic Chemistry:
As a derivative of phenethylamine, 2-(4-bromophenyl)propan-1-amine hydrochloride is used as a reagent in organic chemistry for various reactions. Its stability and solubility properties make it suitable for a range of applications, including the synthesis of complex organic molecules and the study of reaction mechanisms.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 

Relevant academic research and scientific papers

Heterocyclyl sulphonamide derivatives

The present invention relates to the potentiation of glutamate receptor function using certain heterocyclyl sulphonamide derivatives. It also relates to novel heterocyclyl sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.

Sulphonamide derivatives

Glutamate receptor function in a mammal may be potentiated using an effective amount of a compound of formulaR1—L—NHSO2R2??Iin whichR1 represents an unsubstituted or substituted aromatic or heteroaromatic group;R2 represents (1-6C)alkyl, (3-6C)cycloalkyl, (1-6C)fluoroalkyl, (1-6C)chloroalkyl, (2-6C)alkenyl, (1-4C)alkoxy(1-4C)alkyl, phenyl which is unsubstituted or substituted by halogen, (1-4C)alkyl or (1-4C)alkoxy, or a group, of formula R3R4N in which R3 and R4 each independently represents (1-4C)alkyl or, together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, piperidinyl, morpholino, piperazinyl, hexahydroazepinyl or octahydroazocinyl group; andL represents a (2-4C)alkylene chain which is unsubstituted or substituted by one or two substituents selected independently from (1-6C)alkyl, aryl(1-6C)alkyl, (2-6C)alkenyl, aryl(2-6C)alkenyl and aryl, or by two substituents which, together with the carbon atom or carbon atoms to which they are attached form a (3-8C)carbocyclic ring;and pharmaceutically acceptable salts thereof.Also disclosed are compounds of formula I, processes for preparing them and pharmaceutical compositions containing them.